AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Kumetrix, Inc. (29524 Union City Blvd., Union City, CA; Tel: 510/476-0950; Website: kumetrix.com), a privately held medical devices company, said it had received a $100,000 SBIR grant from the National Sciences Foundation (NSF). The funds will be used to further develop the company's painless blood glucose monitoring device for diabetics.
The device consists of a disposable cartridge containing silicon micro-needles and a handheld, battery-powered electronic monitor. The patient simply presses the monitor against the skin, causing a micro-needle to penetrate and draw a blood sample about 1/100th the size of a drop. Blood immediately flows through the needle into a miniature reservoir, where chemical reagents react with the glucose to produce a readout of the blood glucose level. The entire one-step process can be completed neatly in less than a minute.
"This is the second grant we received from the NSF to develop our technology to draw blood and perform blood chemistry on an integrated silicon microchip," says Kumar Subramanian, president of Kumetrix, Inc. "Since the company's ...